Venlafaxine

• A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major d… Not authorised
  2022-502185-24-00 Phase III 4 countries University Medical Center Utrecht
• A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for bipolar depression compared… Recruiting
  2023-506605-19-00 Phase III 5 countries Universitair Medisch Centrum Utrecht
• Early efficacy of ketamine compared to placebo, in add-on therapy of venlafaxine for inpatients with severe unipolar major depressive episod… Recruiting
  2023-506597-12-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for major depressive disorder c… Recruiting
  2023-506617-21-00 Phase III 5 countries Universitair Medisch Centrum Utrecht
• The RED FLASH study Recruiting
  2023-507847-13-00 Phase III 1 country Reinier de Graaf Groep
• The DEXA-PSYCH Study: Dexamethasone Repurposing for Moderate to Severe Depression - A Double-Blind, Randomized, Parallel-Group, Placebo-Cont… Recruiting
  2022-501428-45-00 Phase III 1 country Region Hovedstadens Psykiatriske
• Trial Examining Methods for Antidepressant Discontinuation (TEMPO) Ended
  2024-511997-66-00 Phase IV 1 country Amsterdam UMC Stichting
• Protocol Lay Person Short Title: A Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment o… Ended
  2022-500538-27-00 Phase II/III 6 countries Otsuka Pharmaceutical Development And Commercialization Inc.
• Exploring the Pharmacomicrobiomics of Depression Ended
  2024-518101-18-02 Phase IV 1 country Radboud universitair medisch centrum Stichting

Showing 1–9 of 9 trials